GILEAD SCIENCES, INC.

Q1 2026 13F-HR Detailed Holdings

Location
Foster City, CA
Holdings as of
3/31/2026
Value ($000)
$2,117,784,504
Num holdings
6
Date filed
5/8/2026
Form type
13F-HR
Prev filing
Next filing
SEC
View on sec.gov
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Issuer Name Class CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None Price Filed
5/8/2026
 Price As-Of
3/31/2026
 Price Now
6/23/2026

Other Managers

Num Name File Number
1 Gilead Therapeutics A1 Unlimited Co 028-25083